Kavanaugh Arthur相关文献与解析，生知库 | 链接生命科学的每一步

Mahadevan, Uma; Chaparro, María; Segovia, Michelle; Guo, Xiang; Kulisek, Nicole; Wu, Joseph; Vranic, Ivana; Diehl, Annette; Kavanaugh, Arthur; Dubinsky, Marla

发表日期：2026

文献求助收藏

Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies

乌帕替尼或阿达木单抗对类风湿性关节炎和银屑病关节炎疼痛的影响：随机3期研究结果

期刊:RMD Open

影响因子:4.7

doi:10.1136/rmdopen-2025-005867

Taylor, Peter C; Kavanaugh, Arthur; Bessette, Louis; Fautrel, Bruno; Takeuchi, Tsutomu; Garrison, Andrew; Gao, Tianming; Lippe, Ralph; Caballero, Diane; Phillips, Charles; Mease, Philip J

Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study

filgotinib治疗类风湿性关节炎患者的安全性和有效性：DARWIN 3长期扩展研究的最终结果

期刊:RMD Open

影响因子:4.7

doi:10.1136/rmdopen-2024-004857

Westhovens, Rene; Winthrop, Kevin L; Kavanaugh, Arthur; Greenwald, Maria; Dagna, Lorenzo; Cseuz, Regina; Besuyen, Robin; de Vries, Dick; Modgill, Vikas; Le, Ly Huong; Genovese, Mark C; Emery, Paul; Verschueren, Patrick; Alten, Rieke

关节炎

发表日期：2025

文献求助收藏

Deucravacitinib, a selective, TYK2 inhibitor, in psoriatic arthritis: achievement of minimal disease activity components in a phase 2 trial

Deucravacitinib（一种选择性 TYK2 抑制剂）在银屑病关节炎中的应用：一项 II 期试验显示达到最小疾病活动度指标

期刊:Rheumatology

影响因子:4.4

doi:10.1093/rheumatology/keae580

Kavanaugh, Arthur; Coates, Laura C; Mease, Philip J; Nowak, Miroslawa; Hippeli, Lauren; Lehman, Thomas; Banerjee, Subhashis; Merola, Joseph F

Gastrointestinal Perforation as a Safety Concern Among Patients With Rheumatoid Arthritis Receiving JAK Inhibitor Therapy: A Systematic Review and Network Meta-Analysis

接受JAK抑制剂治疗的类风湿性关节炎患者发生胃肠道穿孔的安全隐患：系统评价和网络荟萃分析

期刊:Arthritis Care & Research

影响因子:3.3

doi:10.1002/acr.25554

Sathapanasiri, Thipsukhon; Meraz, Manuel; Mokri, Hamraz; K Veettil, Sajesh; Wijarnpreecha, Karn; Schlesinger, Naomi; Kavanaugh, Arthur; Chaiyakunapruk, Nathorn

Non-invasive evaluation of Achilles tendon and its enthesis using ultrashort echo time adiabatic T(1ρ) (UTE-Adiab-T(1ρ)) magnetic resonance imaging (MRI) in psoriatic arthritis

利用超短回波时间绝热T(1ρ) (UTE-Adiab-T(1ρ))磁共振成像(MRI)对银屑病关节炎患者的跟腱及其附着点进行无创评估

期刊:European Journal of Radiology

影响因子:3.3

doi:10.1016/j.ejrad.2024.111841

Moazamian, Dina; Mohammadi, Hamidreza Shaterian; Athertya, Jiyo; Daskareh, Mahyar; Ma, Yajun; Guma, Monica; Covey, Dana C; Yaksh, Tony; Singh, Abha; Kavanaugh, Arthur; Chung, Christine B; Du, Jiang; Chang, Eric Y; Jerban, Saeed

Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III Studies (EGALITY and EQUIRA)

使用依那西普生物类似药 GP2015 治疗类风湿性关节炎、银屑病或银屑病关节炎患者的患者报告结局指标：两项 III 期研究（EGALITY 和 EQUIRA）的结果

期刊:Drugs in Research & Development

影响因子:2.1

doi:10.1007/s40268-025-00507-8

Thaçi, Diamant; Gerdes, Sascha; Schulze-Koops, Hendrik; Allanore, Yannick; Kavanaugh, Arthur; Both, Charlotte; Gattu, Sreekanth; Hachaichi, Sohaib; Matucci-Cerinic, Marco

Psoriatic Arthritis Features and Risk of Cardiovascular Events: A Nationwide Cohort Study

银屑病关节炎特征与心血管事件风险：一项全国性队列研究

期刊:Cureus Journal of Medical Science

影响因子:1.3

doi:10.7759/cureus.97377

Sanchez Baez, Roel; Kavanaugh, Arthur; Guma, Monica; Kremer, Joel M; Reed, George

Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial

Sonelokimab，一种用于治疗活动性银屑病关节炎的IL-17A/IL-17F抑制纳米抗体：一项随机、安慰剂对照的II期试验

期刊:Nature Medicine

影响因子:

doi:10.1038/s41591-025-03971-6

McInnes, Iain B; Coates, Laura C; Mease, Philip J; Ogdie, Alexis; Kavanaugh, Arthur; Eder, Lihi; Schett, Georg; Kivitz, Alan; McGonagle, Dennis; Brennan, Nuala; Godwood, Alex; Cullen, Eva; Reich, Kristian; Ritchlin, Christopher T; Merola, Joseph F

Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial

使用阿普米司特治疗早期少关节型银屑病关节炎：FOREMOST随机对照试验第16周的主要结果

期刊:Annals of the Rheumatic Diseases

影响因子:20.6

doi:10.1136/ard-2024-225833

Gossec, Laure; Coates, Laura C; Gladman, Dafna D; Aelion, Jacob A; Vasandani, Jitendra; Pinter, Andreas; Merola, Joseph F; Kavanaugh, Arthur; Reddy, Jyotsna; Wang, Rebecca; Brunori, Michele; Klyachkin, Yuri; Deignan, Cynthia; Mease, Philip J

Pregnancy Outcomes After Maternal or Paternal Exposure to Tofacitinib Across Clinical Programs

临床项目中，母亲或父亲接触托法替尼后的妊娠结局

Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies

乌帕替尼或阿达木单抗对类风湿性关节炎和银屑病关节炎疼痛的影响：随机3期研究结果

Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study

filgotinib治疗类风湿性关节炎患者的安全性和有效性：DARWIN 3长期扩展研究的最终结果

Deucravacitinib, a selective, TYK2 inhibitor, in psoriatic arthritis: achievement of minimal disease activity components in a phase 2 trial

Deucravacitinib（一种选择性 TYK2 抑制剂）在银屑病关节炎中的应用：一项 II 期试验显示达到最小疾病活动度指标

Gastrointestinal Perforation as a Safety Concern Among Patients With Rheumatoid Arthritis Receiving JAK Inhibitor Therapy: A Systematic Review and Network Meta-Analysis

接受JAK抑制剂治疗的类风湿性关节炎患者发生胃肠道穿孔的安全隐患：系统评价和网络荟萃分析

Non-invasive evaluation of Achilles tendon and its enthesis using ultrashort echo time adiabatic T(1ρ) (UTE-Adiab-T(1ρ)) magnetic resonance imaging (MRI) in psoriatic arthritis

利用超短回波时间绝热T(1ρ) (UTE-Adiab-T(1ρ))磁共振成像(MRI)对银屑病关节炎患者的跟腱及其附着点进行无创评估

Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III Studies (EGALITY and EQUIRA)

使用依那西普生物类似药 GP2015 治疗类风湿性关节炎、银屑病或银屑病关节炎患者的患者报告结局指标：两项 III 期研究（EGALITY 和 EQUIRA）的结果

Psoriatic Arthritis Features and Risk of Cardiovascular Events: A Nationwide Cohort Study

银屑病关节炎特征与心血管事件风险：一项全国性队列研究

Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial

Sonelokimab，一种用于治疗活动性银屑病关节炎的IL-17A/IL-17F抑制纳米抗体：一项随机、安慰剂对照的II期试验

Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial

使用阿普米司特治疗早期少关节型银屑病关节炎：FOREMOST随机对照试验第16周的主要结果